Luminex (LMNX) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Luminex Corporation  (NASDAQ: LMNX)
 

Luminex Growth Comparisons

Select each growth Category to receive further Information





LMNX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 22.41 % 15.92 % 15.08 % 14.89 %
Q / Q Revenue Growth (Q1 MRQ) -0.63 % -1.66 % -2.3 % 2.02 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 27.73 % 1.13 % 6.93 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 4.85 % 3.83 % 3.56 % 3.64 %
Revenue 5 Year Average Growth 11.92 % 7.58 % 10.85 % 9.03 %


LMNX's Growth Comparisons in I. Quarter 2021




Strong but slowing Revenue rise by Luminex of 22.41% year on year , in the first quarter 2021 to 111 millions, was higher than the 15.92% rise in the Medical Equipment & Supplies industry, and 15.08% improvement in the Healthcare sector. Above the average sales gains in the Healthcare and in the Medical Equipment & Supplies industry, helped to elevate overall market growth to 14.89%.

Top-line fell by -0.63% from the fourth quarter. Average annual sales growth for Luminex is 11.92%, while S & P 500's average yearly sales increase is 9.03%, including only Businesses with the first quarter 2021 financial results.


Growth Rates of LMNX's Income in the first quarter 2021


LMNX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 720.17 % 111.17 % 32.5 % 92.71 %
Sequential Operating Income Change (Q1 MRQ) 28.18 % -3.74 % 83.38 % 58.11 %
Y / Y Operating Income Growth (Q1 TTM) - 0.36 % -12.74 % -6.23 %
Sequential Operating Income Growth (Q1 TTM) 27.84 % 20.05 % 9.28 % 19.42 %
Operating Income 5 Year Avg. Change 2.59 % 1 % 2.2 % 8.2 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 1100 % 29.14 % 44.46 % 153.38 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) 264.27 % -36.14 % 144.66 % 61.73 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) 408.3 % -17.6 % -13.56 % 0.07 %
Sequential Income from Cont. Ops. Change (Q1 TTM) 41.73 % 6.94 % 15.74 % 28.52 %
Income from Cont. Ops. 5 Year Avg. Change 3.52 % 4.67 % 10.33 % 76.07 %

LMNX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 1100 % 29.29 % 39.36 % 144.01 %
Q / Q Net Income Growth (Q1 MRQ) 264.27 % -35.02 % 654.36 % 64.84 %
Y / Y Net Income Change (Q1 TTM) 846.62 % -16.16 % -19.18 % -0.39 %
Sequential Net Income Change (Q1 TTM) 41.73 % 7.64 % 17.16 % 27.86 %
Net Income 5 Year Avg. Growth 3.52 % 3.93 % 1.77 % 4.21 %

LMNX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 1800 % 13.67 % 44.46 % 153.38 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) 1800 % -38.23 % 144.66 % 61.73 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 54.55 % - - 34.47 %
EPS from Cont. Ops. 5 Year Avg. Growth -17.81 % -5.03 % 10.33 % 76.07 %



LMNX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 1800 % 13.81 % 39.36 % 76.07 %
Q / Q EPS Net Growth (Q1 MRQ) 1800 % -37.15 % 654.36 % 64.84 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - -27.73 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 54.55 % - - 32.32 %
EPS Net 5 Year Avg. Change -17.94 % 3.93 % 1.77 % 4.21 %



Reporting 1800% surge year on year in the first quarterEPS, Luminex led the 13.81% rise in the Medical Equipment & Supplies industry, and 39.36% increase in the Healthcare sector. Despite modest earnings per share rises in the Healthcare sector and Medical Equipment & Supplies industry, Luminex Corporation reported above average market earnings per share growth.

The Company's sequential EPS growth rate was very impressive 1800% from the fourth quarter. Average yearly income per share growth for Luminex is -17.94%, while S & P 500's average annual income per share growth is 4.21% over the five years, including only Businesses with the first quarter 2021 earnings results.

LMNX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 127.27 % 101.87 % 156.25 %
Sequential Free Cash Flow Change (Q1 MRQ) - -47.26 % -24.35 % -39.04 %
Y / Y Free Cash Flow Change (Q1 TTM) - 17.62 % 40.36 % -12.8 %
Sequential Free Cash Flow Change (Q1 TTM) -92.96 % 6.62 % 10.43 % 8.85 %
Free Cash Flow 5 Year Avg. Change -2.9 % 12.46 % 14.45 % 20.95 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - -84.63 % -75.89 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - -1.91 %
Y / Y Net Cash Flow Change (Q1 TTM) - -61.45 % - 12.22 %
Sequential Net Cash Flow Change (Q1 TTM) - -71.18 % - -43.24 %
Net Cash Flow 5 Year Avg. Change 46.68 % 29.86 % 45.88 % 111.43 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 239.61 % -1.61 % 6.55 % 1.87 %
Sequential Capital Expenditures Change (Q1 MRQ) -2.84 % -15.55 % -27.85 % -22.75 %
Y / Y Capital Expenditures Change (Q1 TTM) 111.89 % -1.45 % 2.01 % -10.89 %
Sequential Capital Expenditures Change (Q1 TTM) 37.12 % 0.06 % 1.16 % 0.11 %
Capital Expenditures 5 Year Avg. Change - 10.08 % 11.27 % 9.33 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.